Nutritional intervention study with argan oil in man: Effects on lipids and apolipoproteins

Annals of Nutrition and Metabolism

Volumn 49, Issue 3, 2005, Pages 196-201

  Derouiche, A ^a   Cherki, M ^a   Drissi, A ^a   Bamou, Y ^b   El Messal, M ^c   Idrissi Oudghiri, A ^b   Lecerf, J M ^d   Adlouni, A ^a  

^a FACULTÉ DES SCIENCES BEN M SIK   (Morocco)

^b Military Hospital Moulay Ismail   (Morocco)

^c FACULTÉ DES SCIENCES AIN CHOCK   (Morocco)

^d INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Argan oil; Cardiovascular diseases; Lipids; Nutritional intervention study; Olive oil

Indexed keywords

APOLIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; EVALUATION; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

EID: 23844501003     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087072     Document Type: Article

References (34)

1. Kushi LH, Lew RA, Stare FJ, et al: Diet and 20-year mortality from coronary heart disease. The Ireland-Boston Diet-Heart Study. N Engl J Med 1985;312:811-818.
2. Keys A: L'épidémiologie cardiovasculaire des matières grasses dans le régime alimentaire et les décès dus aux affections coronaires. Méd Chir Dig 1982;11:597-599.
3. Esrey KL, Joseph L, Grover SA: Relationship between dietary intake and coronary heart disease mortality. Lipid Research Clinics Prevalence Follow-Up Study. J Clin Epidemiol 1996;49:211-216.
4. Trautwein EA, Rieckhoff D, Kunath-Rau A, Erbersdobler HF: Replacing saturated fat with PUFA-rich (sunflower oil) or MUFA-rich (rapeseed, olive and high-oleic sunflower oil) fats resulted in comparable hypocholesterolemic effects in cholesterol-fed hamsters. Ann Nutr Metab 1999;43:159-172.
5. Keys A, Minotti A, Karvonen MJ: The diet and 15-year death rate in the Seven Countries Study. Am J Epidemiol 1996;124:903-915.
6. Nagyova A, Haban P, Klvanova J, Kadrabova J: Effects of dietary extra virgin olive oil on serum lipid resistance to oxidation and fatty acid composition in elderly lipidemic patients. Bratisl Lek Listy 2003;104:218-221.
7. Olivier MF: Dietary fat and coronary heart disease. Cardiology 1987;74:22-27.
8. Demaison L, Moreau D: Dietary n-3 polyunsaturated fatty acids and coronary heart disease-related mortality: A possible mechanism of action. Cell Mol Life Sci 2002;59:463-477.
9. Baudet M, Dachet C, Lasserre M, Jacotot B: Modification in the composition and metabolic properties of human low density and high density lipoproteins by different fats. J Lipid Res 1984;25:456-468.
10. Esteva O, Baudet M, Lasserre M, Jacotot B: Influence of the fatty acid composition of high-density lipoprotein phospholipids on the cholesterol efflux from cultured fibroblasts. Biochim Biophys Acta 1986;875:174-182.
11. Khallouki F, Younos C, Soulimani R, Oster T, Charrouf Z, Spiegelhalder B, Bartsch H, Owen RW: Consumption of argan oil (Morocco) with its unique profile of fatty acids, tocopherols, squalene, sterols and phenolic compounds should confer valuable cancer chemopreventive effects. Eur J Cancer Prev 2003;12:67-75.
12. Répertoire général des aliments - Ciqual - 1991. Paris, Lavoisier-INRA, 1991.
13. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
14. Berrada Y, Settaf A, Baddouri K, Cherrah Y, Hassar M: L'huile d'argan normalise les pressions artérielles systolique et diastolique des rats spontanément hypertendus. Pharmacologie 1999;47:75-78.
15. Benajiba N, Morel S, De Leiris J, Charrouf Z, Agnaou H: Effet de l'huile d'argan sur la fonction cardiaque au cours de l'ischémie et de la perfusion. Thérapie 2002;57:246-252.
16. Lasserre M, Mendy F, Spielmann D, Jacotot B: Effects of different dietary intake of essential fatty acids on C20:3 omega 6 and C20:4 omega 6 serum levels in human adults. Lipids 1985;20:227-233.
17. Berrada Y, Settaf A, Baddouri K, Cherrah Y, Hassar M: Mise en évidence expérimentale des effets antihypertenseurs et hypocholestérolémiants de l'huile d'argan, Argania sideroxylon. Thérapie 2000;55:375-378.
18. Ferrara LA, Raimondi AS, d'Episcopo L, Guida L, Dello Russo A, Marotta T: Olive oil and reduced need for antihypertensive medications. Arch Intern Med 2000;160:837-842.
19. Ostlund RE Jr, Racette SB, Stenson WF: Effects of trace components of dietary fat on cholesterol metabolism: Phytosterols, oxysterols, and squalene. Nutr Rev 2002;60:349-359.
20. Plat J, Mensink RP: Effects of plant sterols and stanols on lipid metabolism and cardiovascular risk. Nutr Metab Cardiovasc Dis 2001;11:31-40.
21. Drissi A, Girona J, Cherki M, Godàs G, Derouiche A, El Messal M, Saile R, Kettani A, Solà R, Masana L, Adlouni A: Evidence of hypolipemiant and antioxidant properties of argan oil derived from the argan tree (Argania spinosa). Clin Nutr 2004;23:1159-1166.
22. Wardlaw GM, Snook JT: Effect of diets high in butter, corn oil, or high-oleic acid sunflower oil on serum lipids and apolipoproteins in men. Am J Clin Nutr 1990;51:815-821.
23. Hokanson JE, Austin MA: Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213-219.
24. Muller M: Is hypertriglyceridaemia an independent risk factor for coronary heart disease? The epidemiological evidence. Eur Heart J 1998;19(suppl H):H18-H22.
25. Berrougui H, Ettaib A, Herrera Gonzalez MD, Alvarez de Sotomayor M, Bennani-Kabchi A, Hmamouchi M: Hypolipidemic and hypocholesterolemic effect of argan oil (Argania spinosa L.) in Meriones shawi rats. J Ethnopharmacol 2003;89:15-18.
26. Miller N: The evidence for the antiatherogenicity of high-density lipoprotein in man. Lipids 1978;13:914-919.
27. Brousseau ME, Stucchi AF, Vespa DB, Schaefer EJ, Nicolosi RJ: A diet enriched in mono-unsaturated fats decreases low-density lipoprotein concentrations in cynomolgus monkeys by a different mechanism than does a diet enriched in polyunsaturated fats. J Nutr 1993;123:2049-2058.
28. Cowin IS, Emmett PM; ALSPAC Study Team; Avon Longitudinal Study of Pregnancy and Childhood: Associations between dietary intakes and blood cholesterol concentrations at 31 months. Eur J Clin Nutr 2001;55:39-49.
29. Bunyard LB, Dennis KE, Nicklas BJ: Dietary intake and changes in lipoprotein lipids in obese, postmenopausal women placed on an American Heart Association Step 1 diet. J Am Diet Assoc 2002;102:52-57.
30. Barkia A, Puchois P, Ghalim N, Torpier G, Barbaras R, Ailhaud G, Fruchart JC: Differential role of apolipoprotein A-I containing particles in cholesterol efflux from adipose cells. Atherosclerosis 1991;87:135-146.
31. Parra H, Fievet C, Boniface B, Bertrand M, Duthieul P, Fruchart JC: Lipoproteins, apolipoproteins and coronary artery disease assessed by coronary arteriography; in De Genes JL, et al (eds): Latent Dyslipoproteinemias and Atherosclerosis. New York, Raven Press, 1984, pp 187-189.
32. Osada J, Fernandez-Sanchez A, Diaz-Morillo JL, Aylagas H, Miro-Obradors MJ, Ordovas J, Palacios-Alaiz E: Hepatic expression of apolipoprotein A-I gene in rats is upregulated by monounsaturated fatty acid diet. Biochem Biophys Res Commun 1991;180:162-168.
33. Calleja L, Trallero MC, Carrizosa C, Mendez M, Palacios-Alaiz E, Osada J: Effects of dietary fat amount and saturation on the regulation of hepatic mRNA and plasma apolipoprotein A-I in rats. Atherosclerosis 2000;152:69-78.
34. Puiggros C, Chacon P, Armadans LI, Clapes J, Planas M: Effects of oleic-rich and omega-3-rich diets on serum lipid pattern and lipid oxidation in mildly hypercholesterolemic patients. Clin Nutr 2002;21:79-87.